Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant

PURPOSE: To report our experience with dexamethasone 0.7 mg sustained-release intravitreal implant (Ozurdex(®); Allergan, Inc, Irvine, CA) in noninfectious posterior uveitis. METHODS: A retrospective chart review of patients with noninfectious uveitis treated with sustained-release dexamethasone 0.7...

Descripción completa

Detalles Bibliográficos
Autores principales: Myung, Jane S, Aaker, Grant D, Kiss, Szilárd
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000767/
https://www.ncbi.nlm.nih.gov/pubmed/21188153
http://dx.doi.org/10.2147/OPTH.S15696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000767/
https://www.ncbi.nlm.nih.gov/pubmed/21188153
http://dx.doi.org/10.2147/OPTH.S15696

Ejemplares similares